<?xml version="1.0" ?><text author="Kristin Andrud, Hong Xing, Bjarne Gabrielsen, Linda Bloom, Vladimir Mahnir, Stephen Lee, Benedict  T. Green, Jon Lindstrom, William Kem" dateCollected="2019-11-03" id="autogum_academic_doc472" shortTile="investigation-possible" sourceURL="https://www.mdpi.com/1660-3397/17/11/614/htm" speakerCount="0" speakerList="none" title="Investigation of the Possible Pharmacologically Active Forms of the Nicotinic Acetylcholine Receptor Agonist Anabaseine" type="academic">
<head>
<s type="frag">
3	CD	3
.	.	.
</s>
<s type="frag">
Discussion	NN	discussion
</s>
</head>
<p>
<s type="decl">
While	IN	while
most	JJS	most
nAChR	NNP	nAChr
agonists	NNS	agonist
and	CC	and
antagonists	NNS	antagonist
binding	VBG	binding
at	IN	at
ACh	NNP	ACh
orthosteric	JJ	orthosteric
sites	NNS	site
are	VBP	be
basic	JJ	basic
molecules	NNS	molecule
with	IN	with
at	IN	at
least	JJS	least
one	CD	one
ionizable	JJ	ionizable
N	NN	N
,	,	,
there	EX	there
are	VBP	be
exceptions	NNS	exception
,	,	,
including	VBG	include
lophotoxin	NN	lophotoxin
,	,	,
the	DT	the
neonicotinoids	NNS	neonicotinoid
and	CC	and
some	DT	some
recently	RB	recently
synthesized	VBN	synthesize
pyrimidine	NN	pyrimidine
agonists	NNS	agonist
.	.	.
</s>
<s type="decl">
To	TO	To
optimize	VB	optimize
a	DT	a
molecule	NN	molecule
to	TO	to
serve	VB	serve
as	IN	as
a	DT	a
drug	JJ	drug
or	CC	or
selective	JJ	selective
molecular	JJ	molecular
probe	NN	probe
of	IN	of
some	DT	some
receptor	NN	receptor
it	PRP	it
is	VBZ	be
important	JJ	important
to	TO	to
identify	VB	identify
the	DT	the
form	NN	form
in	IN	in
which	WDT	which
it	PRP	it
interacts	VBZ	interact
optimally	RB	optimally
with	IN	with
its	PRP$	its
target	NN	target
.	.	.
</s>
<s type="decl">
In	IN	in
the	DT	the
case	NN	case
of	IN	of
anabaseine	NN	anabaseine
,	,	,
our	PRP$	our
identification	NN	identification
of	IN	of
the	DT	the
cyclic	JJ	cyclic
iminium	NN	iminium
form	NN	form
as	IN	as
the	DT	the
most	RBS	most
active	JJ	active
(	-LRB-	(
and	CC	and
possibly	RB	possibly
the	DT	the
only	RB	only
)	-RRB-	)
form	NN	form
suggests	VBZ	suggest
that	IN	that
structural	JJ	structural
modifications	NNS	modification
that	WDT	that
enhance	VBP	enhance
the	DT	the
basicity	NN	basicity
of	IN	of
its	PRP$	its
tetrahydropyridyl	NN	tetrahydropyridyl
nitrogen	NN	nitrogen
will	MD	will
enhance	VB	enhance
potency	NN	potency
and	CC	and
possibly	RB	possibly
selectivity	NN	selectivity
for	IN	for
the	DT	the
intended	VBN	intend
receptor	NN	receptor
target	NN	target
.	.	.
</s>
<s type="decl">
In	IN	in
fact	NN	fact
,	,	,
a	DT	a
major	JJ	major
improvement	NN	improvement
in	IN	in
stability	NN	stability
occurs	VBZ	occur
with	IN	with
addition	NN	addition
at	IN	at
the	DT	the
3-position	NN	3-position
of	IN	of
the	DT	the
tetrahydropyridyl	JJ	tetrahydropyridyl
ring	NN	ring
of	IN	of
an	DT	an
electron-conjugated	JJ	electron-conjugated
system	NN	system
containing	VBG	contain
an	DT	an
aromatic	JJ	aromatic
ring	NN	ring
,	,	,
as	IN	as
in	IN	in
3-(4-dimethylaminobenzylidene)-anabaseine	JJ	3-(4-dimethylaminobenzylidene)-anabaseine
or	CC	or
3-(2,4-dimethoxybenzylidene)-anabaseine	NN	3-(2,4-dimethoxybenzylidene)-anabaseine
,	,	,
also	RB	also
called	VBN	call
GTS-21	NNP	GTS-21
.	.	.
</s>
<s type="decl">
These	DT	these
anabaseine	JJ	anabaseine
derivatives	NNS	derivative
do	VBP	do
not	RB	not
undergo	VB	undergo
ring	NN	ring
opening	NN	opening
(	-LRB-	(
hydrolysis	NN	hydrolysis
of	IN	of
the	DT	the
imine	NN	imine
bond	NN	bond
)	-RRB-	)
under	IN	under
physiological	JJ	physiological
conditions	NNS	condition
,	,	,
due	JJ	due
to	TO	to
their	PRP$	their
extended	VBN	extend
π	NN	π
electron	NN	electron
conjugation	NN	conjugation
.	.	.
</s>
</p>
<p>
<s type="decl">
Previously	RB	previously
,	,	,
it	PRP	it
was	VBD	be
assumed	VBN	assume
(	-LRB-	(
but	CC	but
not	RB	not
experimentally	RB	experimentally
tested	VBN	tested
)	-RRB-	)
that	IN	that
the	DT	the
cyclic	JJ	cyclic
iminium	NN	iminium
form	NN	form
of	IN	of
anabaseine	NN	anabaseine
is	VBZ	be
the	DT	the
one	CD	one
which	WDT	which
binds	VBZ	bind
avidly	RB	avidly
to	TO	to
the	DT	the
ACh	NNP	ACh
binding	NN	binding
site	NN	site
in	IN	in
nAChRs	NNP	naChr
.	.	.
</s>
<s type="decl">
This	DT	this
form	NN	form
was	VBD	be
modeled	VBN	modeled
to	TO	to
fit	VB	fit
into	IN	into
a	DT	a
muscle	NN	muscle
type	NN	type
homology	NN	homology
model	NN	model
.	.	.
</s>
<s type="decl">
The	DT	the
crystal	JJ	crystal
structure	NN	structure
of	IN	of
the	DT	the
molluscan	NN	molluscan
acetylcholine	JJ	acetylcholine
binding	NN	binding
protein	NN	protein
binding	NN	binding
anabaseine	NN	anabaseine
actually	RB	actually
was	VBD	be
derived	VBN	derive
from	IN	from
crystals	NNS	crystal
containing	VBG	contain
both	CC	both
the	DT	the
cyclic	JJ	cyclic
iminium	NN	iminium
and	CC	and
the	DT	the
open-chain	JJ	open-chain
monocationic	JJ	monocationic
form	NN	form
of	IN	of
anabaseine	NN	anabaseine
occupying	VBG	occupy
some	DT	some
of	IN	of
the	DT	the
five	CD	five
identical	JJ	identical
binding	NN	binding
sites	NNS	site
.	.	.
</s>
<s type="decl">
Unlike	IN	unlike
the	DT	the
cyclic	JJ	cyclic
iminium	NN	iminium
,	,	,
the	DT	the
ammonium-ketone	JJ	ammonium-ketone
form	NN	form
ammonium	NN	ammonium
group	NN	group
did	VBD	do
not	RB	not
insert	VB	insert
into	IN	into
the	DT	the
“	``	"
aromatic	JJ	aromatic
box	NN	box
.	.	.
”	''	"
</s>
<s type="decl">
In	IN	in
the	DT	the
preparation	NN	preparation
of	IN	of
the	DT	the
AChBP-anabaseine	NNP	AChBP-anabaseine
crystals	NNS	crystal
very	RB	very
high	JJ	high
anabaseine	JJ	anabaseine
concentrations	NNS	concentration
were	VBD	be
used	VBN	use
so	IN	so
that	IN	that
most	JJS	most
of	IN	of
the	DT	the
five	CD	five
sites	NNS	site
would	MD	would
be	VB	be
occupied	VBN	occupy
;	:	;
therefore	RB	therefore
the	DT	the
presence	NN	presence
of	IN	of
the	DT	the
ammonium-ketone	JJ	ammonium-ketone
form	NN	form
in	IN	in
the	DT	the
crystal	JJ	crystal
structure	NN	structure
does	VBZ	do
not	RB	not
necessarily	RB	necessarily
indicate	VB	indicate
that	IN	that
this	DT	this
form	NN	form
of	IN	of
anabaseine	NN	anabaseine
would	MD	would
bind	VB	bind
to	TO	to
AChBPs	NNP	AChBPs
and	CC	and
nAChRs	NNP	naChr
at	IN	at
the	DT	the
low	JJ	low
concentrations	NNS	concentration
of	IN	of
anabaseine	NN	anabaseine
that	WDT	that
occur	VBP	occur
in	IN	in
our	PRP$	our
in	IN	in
vitro	FW	vitro
functional	JJ	functional
and	CC	and
binding	NN	binding
studies	NNS	study
.	.	.
</s>
</p>
<p>
<s type="decl">
The	DT	the
ability	NN	ability
of	IN	of
a	DT	a
variety	NN	variety
of	IN	of
2-(aryl)-1,4,5,6-tetrahydropyrmidines	NNS	2-Parylg-tedretretakitretrenredre
to	TO	to
block	VB	block
neuromuscular	JJ	neuromuscular
nAChRs	NNP	naChr
and	CC	and
produce	VB	produce
teratogenic	JJ	teratogenic
effects	NNS	effect
in	IN	in
chick	NN	chick
embryos	NNS	embryos
was	VBD	be
reported	VBN	report
long	RB	long
ago	RB	ago
.	.	.
</s>
<s type="decl">
Some	DT	some
of	IN	of
these	DT	these
compounds	NNS	compound
were	VBD	be
reported	VBN	report
to	TO	to
be	VB	be
nAChR	NNP	nAChr
agonists	NNS	agonist
.	.	.
</s>
<s type="decl">
The	DT	the
only	JJ	only
study	NN	study
of	IN	of
PTHP	NNP	PTHP
on	IN	on
neurons	NNS	neuron
was	VBD	be
that	IN	that
of	IN	of
Upshall	NNP	Upshall
et	FW	et
al.	FW	al.
on	IN	on
leech	NN	leech
Retzius	FW	retzius
cells	NNS	cell
.	.	.
</s>
<s type="decl">
Our	PRP$	our
results	NNS	result
also	RB	also
indicate	VBP	indicate
that	IN	that
PTHP	NNP	PTHP
is	VBZ	be
a	DT	a
potent	JJ	potent
agonist	NN	agonist
at	IN	at
neuronal	NN	neuronal
as	RB	as
well	RB	well
as	IN	as
neuromuscular	JJ	neuromuscular
nAChRs	NNS	naChr
.	.	.
</s>
<s type="decl">
The	DT	the
2-aryl	JJ	2-aryl
compounds	NNS	compound
reported	VBN	report
in	IN	in
the	DT	the
Brimblecombe	FW	Brimblecombe
et	FW	et
al.	FW	al.
study	NN	study
did	VBD	do
not	RB	not
include	VB	include
PTHP	JJ	PTHP
or	CC	or
other	JJ	other
compounds	NNS	compound
having	VBG	have
a	DT	a
2-(3-pyridyl)-	JJ	2-(3-pyridyl)-
substituent	NN	substituent
,	,	,
which	WDT	which
is	VBZ	be
known	VBN	know
to	TO	to
be	VB	be
essential	JJ	essential
for	IN	for
the	DT	the
agonist	NN	agonist
activity	NN	activity
of	IN	of
nicotine	NN	nicotine
and	CC	and
of	IN	of
anabaseine	NN	anabaseine
.	.	.
</s>
<s type="decl">
For	IN	for
PTHP	NNP	PTHP
to	TO	to
be	VB	be
equipotent	JJ	equipotent
with	IN	with
anabaseine	NN	anabaseine
,	,	,
based	VBN	base
on	IN	on
the	DT	the
I+	NNP	I+
form	NN	form
being	VBG	be
the	DT	the
only	RB	only
active	JJ	active
form	NN	form
,	,	,
its	PRP$	its
EC50	NN	EC50
would	MD	would
need	VB	need
to	TO	to
be	VB	be
~1/3	NN	C193
of	IN	of
the	DT	the
EC50	NNP	EC50
of	IN	of
anabaseine	NN	anabaseine
,	,	,
since	IN	since
the	DT	the
anabaseine	NN	anabaseine
(	-LRB-	(
I+	NNP	I+
)	-RRB-	)
is	VBZ	be
~1/3	JJ	C193
of	IN	of
its	PRP$	its
total	JJ	total
concentration	NN	concentration
.	.	.
</s>
<s type="decl">
The	DT	the
data	NNS	datum
for	IN	for
PTHP	NNP	PTHP
and	CC	and
anabaseine	NN	anabaseine
in	IN	in
<figure>
Figure	NNP	Figure
3	CD	3
</figure>
and	CC	and
<figure>
Figure	NNP	Figure
4	CD	4
</figure>
and	CC	and
in	IN	in
Table	NNP	table
1	CD	1
,	,	,
indicate	VBP	indicate
that	IN	that
PTHP	NNP	PTHP
has	VBZ	have
approximately	RB	approximately
30	CD	@card@
%	NN	%
of	IN	of
the	DT	the
potency	NN	potency
predicted	VBN	predict
for	IN	for
the	DT	the
anabaseine	JJ	anabaseine
cyclic	JJ	cyclic
iminium	NN	iminium
form	NN	form
.	.	.
</s>
<s type="decl">
One	CD	One
possible	JJ	possible
explanation	NN	explanation
for	IN	for
this	DT	this
slightly	RB	slightly
inferior	JJ	inferior
potency	NN	potency
is	VBZ	be
that	IN	that
the	DT	the
additional	JJ	additional
N	NN	N
on	IN	on
the	DT	the
tetrahydropyrmidinyl	NN	tetrahydropyrmidinyl
ring	NN	ring
must	MD	must
form	VB	form
an	DT	an
H	NN	H
bond	NN	bond
with	IN	with
some	DT	some
other	JJ	other
atom	NN	atom
within	IN	within
the	DT	the
aromatic	JJ	aromatic
box	NN	box
of	IN	of
the	DT	the
nAChR	NNP	nAChr
orthosteric	JJ	orthosteric
binding	NN	binding
site	NN	site
and	CC	and
this	DT	this
may	MD	may
be	VB	be
energetically	RB	energetically
unfavorable	JJ	unfavorable
.	.	.
</s>
</p>
<p>
<s type="decl">
While	IN	while
2,3′-bipyridyl	NN	2,3′-bipyridyl
displayed	VBN	display
only	RB	only
a	DT	a
marginal	JJ	marginal
potency	NN	potency
at	IN	at
vertebrate	JJ	vertebrate
receptors	NNS	receptor
that	WDT	that
could	MD	could
be	VB	be
predicted	VBN	predict
from	IN	from
its	PRP$	its
pKa	NN	pKa
,	,	,
it	PRP	it
has	VBZ	have
been	VBN	be
found	VBN	find
to	TO	to
be	VB	be
quite	RB	quite
paralytic	JJ	paralytic
to	TO	to
insects	NNS	insect
and	CC	and
crustaceans	NNS	crustacean
.	.	.
</s>
<s type="decl">
At	IN	at
least	JJS	least
some	DT	some
arthropod	JJ	arthropod
nAChRs	NNPS	naChr
are	VBP	be
known	VBN	know
to	TO	to
not	RB	not
require	VB	require
a	DT	a
cationic	JJ	cationic
ligand	NN	ligand
for	IN	for
activation	NN	activation
,	,	,
as	RB	as
shown	VBN	show
by	IN	by
many	JJ	many
studies	NNS	study
with	IN	with
neonicotinoid	NN	neonicotinoid
insecticides	NNS	insecticide
such	JJ	such
as	IN	as
imidachloprid	NN	imidachloprid
.	.	.
</s>
<s type="decl">
These	DT	these
neonicotinoids	NNS	neonicotinoid
also	RB	also
display	VBP	display
a	DT	a
limited	JJ	limited
activity	NN	activity
at	IN	at
vertebrate	JJ	vertebrate
nAChRs	NNP	naChr
.	.	.
</s>
<s type="decl">
It	PRP	it
seems	VBZ	seem
likely	JJ	likely
that	IN	that
2,3′-bipyridyl	NN	2,3′-bipyridyl
affects	VBZ	affect
some	DT	some
arthropod	JJ	arthropod
nAChRs	NNS	naChr
through	IN	through
its	PRP$	its
unionized	JJ	unionized
form	NN	form
.	.	.
</s>
</p>
<p>
<s type="sub">
One	PRP	One
can	MD	can
speculate	VB	speculate
as	RB	as
to	TO	to
what	WP	what
advantage(s)	NNS	advantage(s)
might	MD	might
accrue	VB	accrue
to	TO	to
an	DT	an
organism	NN	organism
(	-LRB-	(
in	IN	in
this	DT	this
case	NN	case
,	,	,
a	DT	a
hoplonemertine	NN	hoplonemertine
or	CC	or
ant	NN	ant
)	-RRB-	)
to	TO	to
produce	VB	produce
and	CC	and
secrete	VB	secrete
an	DT	an
imine-bond	NN	imine-bond
containing	VBG	contain
toxin	NN	toxin
like	IN	like
anabaseine	NN	anabaseine
.	.	.
</s>
<s type="decl">
The	DT	the
entire	JJ	entire
body	NN	body
wall	NN	wall
integument	NN	integument
as	RB	as
well	RB	well
as	IN	as
the	DT	the
contiguous	JJ	contiguous
epithelium	NN	epithelium
of	IN	of
the	DT	the
anterior	JJ	anterior
proboscis	NN	proboscis
of	IN	of
<hi rend="italic">
P.	FW	P.
peregrina	FW	peregrina
</hi>
contains	VBZ	contain
very	RB	very
high	JJ	high
concentrations	NNS	concentration
of	IN	of
anabaseine	NN	anabaseine
.	.	.
</s>
<s type="decl">
The	DT	the
proboscis	NN	proboscis
everts	VBZ	evert
and	CC	and
wraps	VBZ	wrap
around	IN	around
the	DT	the
prey	NN	prey
during	IN	during
its	PRP$	its
capture	NN	capture
allowing	VBG	allow
extensive	JJ	extensive
contact	NN	contact
of	IN	of
this	DT	this
epithelium	NN	epithelium
with	IN	with
its	PRP$	its
annelid	NN	annelid
prey	NN	prey
.	.	.
</s>
<s type="sub">
The	DT	the
mineralized	JJ	mineralize
stylet	NN	stylet
of	IN	of
the	DT	the
proboscis	NN	proboscis
can	MD	can
be	VB	be
observed	VBN	observe
to	TO	to
produce	VB	produce
multiple	JJ	multiple
punctures	NNS	puncture
of	IN	of
the	DT	the
prey	NN	prey
integument	NN	integument
,	,	,
which	WDT	which
should	MD	should
further	RBR	far
facilitate	VB	facilitate
envenomation	NN	envenomation
.	.	.
</s>
<s type="decl">
In	IN	in
addition	NN	addition
,	,	,
potential	JJ	potential
predators	NNS	predator
will	MD	will
also	RB	also
be	VB	be
exposed	VBN	expose
in	IN	in
these	DT	these
ways	NNS	way
to	TO	to
anabaseine	JJ	anabaseine
and	CC	and
related	VBN	relate
alkaloids	NNS	alkaloid
.	.	.
</s>
<s type="decl">
Perhaps	RB	perhaps
a	DT	a
major	JJ	major
advantage	NN	advantage
of	IN	of
possessing	VBG	possessing
an	DT	an
imine	NN	imine
bond	NN	bond
,	,	,
besides	VBZ	beside
an	DT	an
enhanced	VBN	enhance
affinity	NN	affinity
for	IN	for
the	DT	the
nAChR	NNP	nAChr
orthosteric	JJ	orthosteric
site	NN	site
,	,	,
is	VBZ	be
its	PRP$	its
low	JJ	low
basicity	NN	basicity
,	,	,
which	WDT	which
allows	VBZ	allow
the	DT	the
unionized	JJ	unionized
form	NN	form
to	TO	to
reach	VB	reach
a	DT	a
relatively	RB	relatively
high	JJ	high
concentration	NN	concentration
in	IN	in
the	DT	the
neutral	JJ	neutral
pH	NN	pH
range	NN	range
of	IN	of
the	DT	the
marine	JJ	marine
environment	NN	environment
and	CC	and
thereby	RB	thereby
enhance	VB	enhance
passive	JJ	passive
diffusion	NN	diffusion
across	IN	across
the	DT	the
integument	NN	integument
of	IN	of
the	DT	the
prey	NN	prey
or	CC	or
predator	NN	predator
.	.	.
</s>
<s type="decl">
The	DT	the
integument	NN	integument
of	IN	of
a	DT	a
marine	JJ	marine
organism	NN	organism
exposed	VBN	expose
to	TO	to
sea	NN	sea
water	NN	water
is	VBZ	be
likely	JJ	likely
to	TO	to
have	VB	have
a	DT	a
pH	NN	pH
near	IN	near
8	CD	8
,	,	,
well	RB	well
above	IN	above
the	DT	the
pH	NN	pH
range	NN	range
in	IN	in
which	WDT	which
anabaseine	NN	anabaseine
is	VBZ	be
primarily	RB	primarily
ionized	VBN	ionize
.	.	.
</s>
<s type="decl">
Thus	RB	thus
,	,	,
the	DT	the
toxin	NN	toxin
has	VBZ	have
a	DT	a
much	RB	much
better	JJR	good
chance	NN	chance
of	IN	of
entering	VBG	enter
the	DT	the
prey/predator	JJ	prey/predator
than	IN	than
would	MD	would
anabaseine	JJ	anabaseine
,	,	,
the	DT	the
more	RBR	more
basic	JJ	basic
secondary	JJ	secondary
amine	NN	amine
analog	NN	analog
of	IN	of
anabaseine	NN	anabaseine
.	.	.
</s>
</p>
</text>